FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307340077> ?p ?o ?g. }

• W4307340077 endingPage "3777" @default.
• W4307340077 startingPage "3770" @default.
• W4307340077 abstract "Revision anterior cruciate ligament (ACL) reconstruction is being performed at an increasing rate. Previous literature has suggested that autograft ACL reconstruction is a better option than allograft in revision surgery, although the optimal autograft choice remains unknown. The all-soft tissue quadriceps tendon (ASTQT) autograft has been found to be an effective option for primary ACL reconstruction. However, few studies have evaluated ASTQT autograft in revision ACL reconstruction.The purpose of this study was to evaluate the ASTQT autograft in revision ACL reconstruction in athletes compared with bone-patellar tendon-bone (BTB) autograft. We hypothesized that the ASTQT autograft would lead to similar return to play, time to return to play, retear rate, and patient-reported outcomes compared with BTB autograft.Cohort study; Level of evidence, 3.A retrospective study was performed on all athletes undergoing revision ACL reconstruction between August 2013 and December 2019 at a single institution. Patients participating in high school or college athletics undergoing first-time revision with either ASTQT or BTB autograft with ≥2 years of follow-up were included. Demographic variables, complications, return to sports, and outcome scores including the International Knee Documentation Committee (IKDC) and Lysholm were collected and compared between the 2 cohorts.A total of 58 revision ACL reconstructions were included, with 32 in the ASTQT cohort and 26 in the BTB cohort. Return to sports at the same level occurred in 62.5% of the ASTQT group and 53.8% of the BTB group. The ASTQT group returned to sports significantly faster than the BTB group (8.9 vs 10.3 months; P = .020). There was no difference in retear rates (3.1%, ASTQT; 7.7%, BTB) or other complications between the 2 groups. The IKDC scores were significantly higher at the 6- and 12-month follow-up for the ASTQT autograft group compared with the BTB group (6 months: ASTQT, 71.3; BTB, 61.7, P = .001; 12 months: ASTQT, 82.7; BTB, 78.6; P = .021). Lysholm scores were also greater in the ASTQT cohort at these time points (6 months: ASTQT, 75.1; BTB, 63.6; P < .001; 12 months: ASTQT, 82.0; BTB, 74.5; P < .001). However, IKDC and Lysholm scores were similar between both groups at final follow-up (IKDC: ASTQT, 82.9; BTB, 81.7; P = .344; Lysholm: ASTQT, 83.0; BTB, 81.0; P = .104) There was no significant clinical difference in the absolute difference in scores or rate of achieving clinical thresholds between the 2 cohorts.ASTQT autograft for revision ACL in athletes has similar outcomes compared with BTB autograft. However, the ASTQT may possibly afford quicker return to sports and better early improvements in patient-reported outcomes that normalize by 1 year. The soft tissue quadriceps autograft should be considered a viable graft option in revision ACL reconstruction in athletes." @default.
• W4307340077 created "2022-10-31" @default.
• W4307340077 creator A5006695425 @default.
• W4307340077 creator A5013536611 @default.
• W4307340077 creator A5015896802 @default.
• W4307340077 creator A5087645736 @default.
• W4307340077 date "2022-10-26" @default.
• W4307340077 modified "2023-10-17" @default.
• W4307340077 title "All-Soft Tissue Quadriceps Tendon Autograft in Revision Anterior Cruciate Ligament Reconstruction in Athletes: Comparison to Bone-Patellar Tendon-Bone Autograft With at Least a 2-Year Follow-up" @default.
• W4307340077 cites W1950616605 @default.
• W4307340077 cites W1992589729 @default.
• W4307340077 cites W1992707983 @default.
• W4307340077 cites W1997051285 @default.
• W4307340077 cites W2016333375 @default.
• W4307340077 cites W2027313695 @default.
• W4307340077 cites W2063124204 @default.
• W4307340077 cites W2073944257 @default.
• W4307340077 cites W2125871337 @default.
• W4307340077 cites W2128286751 @default.
• W4307340077 cites W2149899163 @default.
• W4307340077 cites W2161272152 @default.
• W4307340077 cites W2172729941 @default.
• W4307340077 cites W2203288860 @default.
• W4307340077 cites W2518393202 @default.
• W4307340077 cites W2594459705 @default.
• W4307340077 cites W2620466723 @default.
• W4307340077 cites W2750674281 @default.
• W4307340077 cites W2796004928 @default.
• W4307340077 cites W2898523886 @default.
• W4307340077 cites W2924631000 @default.
• W4307340077 cites W2956476677 @default.
• W4307340077 cites W2987875520 @default.
• W4307340077 cites W3130544050 @default.
• W4307340077 cites W3137343661 @default.
• W4307340077 cites W3181406875 @default.
• W4307340077 cites W3197258581 @default.
• W4307340077 cites W3197416930 @default.
• W4307340077 cites W3204318993 @default.
• W4307340077 cites W4226444299 @default.
• W4307340077 doi "https://doi.org/10.1177/03635465221126523" @default.
• W4307340077 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36285655" @default.
• W4307340077 hasPublicationYear "2022" @default.
• W4307340077 type Work @default.
• W4307340077 citedByCount "3" @default.
• W4307340077 countsByYear W43073400772023 @default.
• W4307340077 crossrefType "journal-article" @default.
• W4307340077 hasAuthorship W4307340077A5006695425 @default.
• W4307340077 hasAuthorship W4307340077A5013536611 @default.
• W4307340077 hasAuthorship W4307340077A5015896802 @default.
• W4307340077 hasAuthorship W4307340077A5087645736 @default.
• W4307340077 hasConcept C126322002 @default.
• W4307340077 hasConcept C136948725 @default.
• W4307340077 hasConcept C141071460 @default.
• W4307340077 hasConcept C167135981 @default.
• W4307340077 hasConcept C1862650 @default.
• W4307340077 hasConcept C2776514716 @default.
• W4307340077 hasConcept C2778434673 @default.
• W4307340077 hasConcept C2780105995 @default.
• W4307340077 hasConcept C2780887989 @default.
• W4307340077 hasConcept C2781054738 @default.
• W4307340077 hasConcept C2991944018 @default.
• W4307340077 hasConcept C71924100 @default.
• W4307340077 hasConcept C72563966 @default.
• W4307340077 hasConceptScore W4307340077C126322002 @default.
• W4307340077 hasConceptScore W4307340077C136948725 @default.
• W4307340077 hasConceptScore W4307340077C141071460 @default.
• W4307340077 hasConceptScore W4307340077C167135981 @default.
• W4307340077 hasConceptScore W4307340077C1862650 @default.
• W4307340077 hasConceptScore W4307340077C2776514716 @default.
• W4307340077 hasConceptScore W4307340077C2778434673 @default.
• W4307340077 hasConceptScore W4307340077C2780105995 @default.
• W4307340077 hasConceptScore W4307340077C2780887989 @default.
• W4307340077 hasConceptScore W4307340077C2781054738 @default.
• W4307340077 hasConceptScore W4307340077C2991944018 @default.
• W4307340077 hasConceptScore W4307340077C71924100 @default.
• W4307340077 hasConceptScore W4307340077C72563966 @default.
• W4307340077 hasIssue "14" @default.
• W4307340077 hasLocation W43073400771 @default.
• W4307340077 hasLocation W43073400772 @default.
• W4307340077 hasOpenAccess W4307340077 @default.
• W4307340077 hasPrimaryLocation W43073400771 @default.
• W4307340077 hasRelatedWork W1787695530 @default.
• W4307340077 hasRelatedWork W1977301539 @default.
• W4307340077 hasRelatedWork W2005880590 @default.
• W4307340077 hasRelatedWork W2045669123 @default.
• W4307340077 hasRelatedWork W2060669511 @default.
• W4307340077 hasRelatedWork W2090651519 @default.
• W4307340077 hasRelatedWork W2108100901 @default.
• W4307340077 hasRelatedWork W2137914951 @default.
• W4307340077 hasRelatedWork W2417736949 @default.
• W4307340077 hasRelatedWork W1878995062 @default.
• W4307340077 hasVolume "50" @default.
• W4307340077 isParatext "false" @default.
• W4307340077 isRetracted "false" @default.
• W4307340077 workType "article" @default.